For pathophysiological explorations of platelet proteome changes in patients with lung cancer we concentrated on four candidates described to be involved in the processing of coagulation proteins, which are F13A1 and the ER proteins P4HB, CALR and HSPA5. This evidence concerns the gene P4HB and lung carcinoma.